Invention Grant
US07902191B2 Histamine H3 receptor antagonists, preparation and therapeutic uses
失效
组胺H3受体拮抗剂，制剂和治疗用途
- Patent Title: Histamine H3 receptor antagonists, preparation and therapeutic uses
- Patent Title (中): 组胺H3受体拮抗剂，制剂和治疗用途
-
Application No.: US10598262Application Date: 2005-02-22
-
Publication No.: US07902191B2Publication Date: 2011-03-08
- Inventor: Lisa Selsam Beavers , Robert Alan Gadski , Philip Arthur Hipskind , Cynthia Darshini Jesudason , Karen Lynn Lobb , Richard Todd Pickard , Craig William Lindsley
- Applicant: Lisa Selsam Beavers , Robert Alan Gadski , Philip Arthur Hipskind , Cynthia Darshini Jesudason , Karen Lynn Lobb , Richard Todd Pickard , Craig William Lindsley
- Applicant Address: US IN Indianapolis
- Assignee: Eli Lilly and Company
- Current Assignee: Eli Lilly and Company
- Current Assignee Address: US IN Indianapolis
- Agent Dan L. Wood
- International Application: PCT/US2005/005491 WO 20050222
- International Announcement: WO2005/082893 WO 20050909
- Main IPC: A01N43/40
- IPC: A01N43/40 ; A61K31/445 ; A61K31/497 ; A61K31/535 ; C07D207/00 ; C07D211/06 ; C07D295/00 ; C07D403/00 ; C07D413/00
Abstract:
The present invention discloses novel compounds of Formula I or pharmaceutically acceptable salts thereof which have histamine-H3 receptor antagonist activity as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising compounds of Formula I as well as methods of using them to treat obesity and other histamine H3 receptor-related diseases.
Public/Granted literature
- US20070155754A1 Histamine h3 receptor antagonists, preparation and therapeutic uses Public/Granted day:2007-07-05
Information query
IPC分类:
